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Bcl-xL overexpression protects from apoptosis induced by HMG- intracellular checkpoint of apoptosis and comprises nearly
CoA reductase inhibitors in murine tubular cells. a dozen mammalian proteins [2]. Bcl-2-related proteins
Background. Hyperplasia is attributed to enhanced tubular are localized in the outer mitochondrial and nuclear mem-cell proliferation with unbalanced cell death. The 3-hydroxy-
branes as well as in the endoplasmic reticulum. Both inhib-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors
itors and stimulators of apoptosis exist within the family,induce apoptosis in a variety of cell lines, including proximal
tubular cells. However, the mechanisms by which statins induce suggesting the general model that apoptosis is contingent
apoptosis in tubular cells have not been fully addressed. on the ratio of pro- and antiapoptotic proteins, perhaps
Methods. Apoptosis induced by simvastatin was measured in acting as homodimers and heterodimers [3–4]. Bcl-2 andmurine tubular cells with and without overexpressing Bcl-xL.
its antiapoptotic congeners, like Bcl-xL, may function asExpression of genes implicated in cell death was studied by
Northern and Western blot. a “guardian” against mitochondrial initiation of caspase
Results. The treatment of proliferating murine tubular cells activation. In addition, part of the antiapoptotic effect
(MCT) with simvastatin induced apoptosis in a time- and dose- of Bcl-xL may therefore be attributed to the inhibition
dependent manner (0.1 to 1mol/L). Apoptosis was correlated
of a direct cytotoxic effect of proapoptotic members ofwith Bcl-xL mRNA and protein down-regulation. By contrast,
the family such as Bax and Bak [5]. While Bcl-xL isthe treatment with simvastatin did not modify the expression
of the proapoptotic protein Bax. Simvastatin treatment was readly detected in kidney, the levels of Bcl-2 in the adult
associated with cytochrome C release from the mitochondria kidney are low [6, 7]. Down-regulation of antiapoptotic
to the cytosol. We also observed the presence of active caspase genes promote activation of caspases (proteases) that9 and 3 during apoptosis induced by simvastatin. These effects
contribute to apoptosis through disassembly of a cellwere reversed by mevalonate, farnesylpyrophosphate (FPP),
and geranylgeranylpyrophosphate (GGPP), suggesting the in- structure by cleaving several proteins involved in cyto-
volvement of protein prenylation. Simvastatin appears to alter skeleton regulation and destruction of nuclear lamina [8].
the balance between cell-life and death-promoting genes, as Although the beneficial effects of 3-hydroxy-3-methyl-
reflected by the decreased Bcl-xL/Bax ratio. Supporting this
glutaryl coenzyme A (HMG-CoA) reductase inhibitorshypothesis, overexpression of Bcl-xL reduced the amount of
are primarily attributed to their lipid-lowering effects,apoptosis induced by simvastatin by 80% when compared with
control vector-expressing cells. The overexpression of Bcl-xL there may be beneficial effects of these agents indepen-
also prevented the activation of caspase 9 and 3. dent of the blood lipid levels. By inhibiting mevalonate
Conclusion. Our results indicate that down-regulation of synthesis, HMG-CoA reductase inhibitors also preventBcl-xL expression mediates apoptosis induced by statins in
the synthesis of other important isoprenoid intermediatestubular cells. These results may be relevant to the treatment
of disorders characterized by altered tubular proliferation. of the cholesterol biosynthetic pathway, such as farnesyl-
pyrophosphate (FPP) and geranylgeranylpyrophosphate
(GGPP). The isoprenoids are important lipid attachments
Apoptosis or programmed cell death is the innate for posttranslational modification of a variety of proteins,
mechanism by which the organism eliminates unwanted including  subunit of heterotrimeric G proteins, heme
cells [1]. The Bcl-2 family of proteins constitutes a critical a, nuclear lamins, Ras, and Ras-like proteins, such as Rho,
Rab, Rac, Ral, and Rap [9, 10].
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In this paper, we analyzed the expression of different express two- to threefold more Bcl-xL than control vec-
tor-transfected cells [6]. The percentage of similarity be-proteins implicated in the control of apoptosis and we
observed that the treatment with simvastatin decreased tween human Bcl-xL and murine Bcl-xL is approxi-
mately 93%.Bcl-xL mRNA and protein expression. However, the
expression of proapoptotic protein Bax was not modified
Flow cytometry assessment of cell deathwith simvastatin treatment. In addition, overexpression
of Bcl-xL prevented apoptosis induced by simvastatin in Cellular DNA content was assessed by flow cytometry.
For this purpose, cells were cultured in 12-well plates andtubular cells. Finally, apoptosis induced by simvastatin
was correlated with the release of cytochrome C from treated as appropriate. Cells attached to the plate were
collected with trypsin and 2.2 mmol/L EDTA in phos-the mitochondria to the cytosol and activation of caspase
9 and 3.These effects were also prevented by overexpres- phate-buffered saline (PBS) and mixed with detached
cells present in the supernatant. Cells were spun andsion of Bcl-xL. Our results will help to understand the
mechanisms of action of these drugs in apoptosis and resuspended in a solution containing 75 mol/L propid-
ium iodide, 10 mg/L RNase A, and 0.05% Nonidet P-40contribute new strategies for the prevention of tubular
hyperplasia. in PBS; then they were incubated at 4C for 30 minutes
in the dark and analyzed by flow cytometry (Coulter
EPICS XL-MCL flow cytometer, Hialeah, FL, USA)
METHODS
using LYSIS II software. The percentage of cells with
Reagents and chemicals decreased DNA staining (Ao), composed of apoptotic
cells resulting from either fragmentation or decreasedRPMI 1640, penicillin, streptomycin, and trypsin-eth-
ylenediamine tetraacetic acid (EDTA) were obtained chromatin, of a minimum of 5000 to 10,000 cells per
experimental condition were counted. Cell debris werefrom BioWhittaker (Walkersville, MD, USA). Fetal bo-
vine serum (FBS) was from Gibco (Eggenstein, Germany). excluded from analysis by selective gating based on ante-
rior and right angle scatter. As assessed by flow cytome-Simvastatin (from Merck, Sharp, and Dohme Research
Laboratories, Rahway, NJ, USA) was converted to the try, none of solvents of different compounds, up to the
highest dose used in our experimental conditions, in-active compounds as described by Kita, Brown, and
Goldstein [12]. Rabbit anti-Bcl-xL polyclonal antibody duced any significant degree of apoptosis.
(sc-634), rabbit anti-Bax polyclonal antibody (sc-493),
DNA electrophoresisand rabbit anti-Rho A antibody (sc-179) were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Anti-active For the evaluation of DNA fragmentation, 106 cells
were incubated under the different experimental condi-caspase 3 (G748A) was obtained from Promega Corp.
(Madison, WI, USA). Anti-caspase 9 (#9504) antibody tions for 24 hours and assayed as described [15]. At the end
of this period, floating and adherent cells were collected,was from Cell Signaling Technology (Hertfordshire,
UK). Anti-Bid antibody was a generous gift from Dr. rinsed twice with cold PBS, and lysed by incubation in 20
mmol/L EDTA, 50 mmol/L Tris HCl, pH 8, and 0.5%Korsmeyer (Howard Hughes Medical Institute, Harvard
Medical School, Boston, MA, USA). The remaining re- (wt/vol) sodium laurylsarkosine for 30 minutes at 4C.
Cell debris and high-molecular-weight DNA were pre-agents were obtained from Sigma Chemical Co. (St.
Louis, MO, USA) unless specified otherwise. cipitated by centrifugation at 12,000g for 30 minutes at
4C. Supernatants containing fragmented DNA were
Cell culture then treated with proteinase K (0.2 g/L) at 50C for 1
hour and 2 g/L RNAse A at 50C for another hour andMurine tubular cells (MCT) cells are cultured line of
proximal tubular cells harvested originally from the renal run in a 1.5% agarose gel containing ethidium bromide.
Gels were examined and photographed under ultravioletcortex of SJL mice [13]. The cells were maintained in
culture in RPMI 1640 supplemented with penicillin 100 light.
g/mL and streptomycin 100 g/mL and 10% heat-inac-
Immunoblottingtivated fetal calf serum (FCS) as previously described
[14]. A human Bcl-xL cDNA (a generous gift from Craig Cells from different experimental conditions were col-
lected, rinsed twice with cold PBS, and pelleted. CellsB. Thompson, University of Chicago) was cloned into a
vector that contained a 1.2 kb fragment of rat gamma were incubated in lysis buffer containing sodium dodecyl
sulfate (SDS) 10%, glycerol, Tris-HCl, and H2O for 15glutamyl tranferase promoter and the human growth
hormone polyadenylation signal. This vector directs ex- minutes. For immunobloting of cytochrome C, cells were
harvested, washed once with cold PBS, and gently lysedpression in tubular cells [14]. MCT cell lines constitu-
tively expressing human Bcl-xL (MCT-Bcl-xL) or an for 6 minutes in 100 L of lysis buffer [250 mmol/L
sucrose, 80 mmol/L KCl, 500 g/mL digitonin, 1 mmol/Lempty control vector (MCT-wt) were established as pre-
viously described [6]. Bcl-xL overexpressing MCT cells dithiothreitol (DTT), and 0.1 mmol/L phenylmethylsul-
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fonyl fluoride (PMSF), protease inhibitors, in PBS]. Ly- After extensive washing, cells were mounted in 70%
glycerol in PBS and immunofluorescence analysis wassates were centrifuged at 12,000 rpm at 4C for 5 minutes
to obtain the supernatants (cytosolic extract free of mito- then performed with a Leica DM-IRB confocal micro-
scope (Leica DM, Bannockburn, IL, USA).chondria) and the pellets (fraction that contains the mito-
chondria). For immunobloting of RhoA, cells were briefly
Northern blot analysissonicated in 1 mL of PBS containing 2 mmol/L EDTA,
2 mmol/L PMSF, and 1 mol/L pepstatin A. Cell mem- For Northern blotting, 30 g of total RNA was sepa-
rated in 1% agarose gels containing 2.3% formaldehyde.branes were collected by centrifugation at 50,000g for
30 minutes and resuspended in 100 mmol/L Tris HCl, RNA was transferred to nylon membranes (Genescreen
Plus; NEN Life Science, Zaventem, Belgium) and prehy-300 mmol/L NaCl, 1% Triton X-100, and 0.1% SDS,
containing 2 mmol/L EDTA, 2 mmol/L PMSF, and 1 bridized and hybridized at 65C in 6  standard sodium
citrate (SSC), 5  Denhardt’s, 10% dextran sulfate, 1%mol/L pepstain. Protein concentration was calculated
by the BCA method (Pierce Chemical Co., Rockford, SDS, 100 g/mL salmon sperm DNA, and 100 g/mL
polyadenylic acid. The probes were labeled by randomIL, USA). Equal amounts of protein were loaded into
12% acrylamide gels and electrophoresed. The resolved priming and added to the hybridization solution to a
final activity of 1.5  106 cpm/mL. After hybridization,proteins were transferred onto polyvinylidine difluoride
(PVDF) membranes (Immobilon, Millipore Corporation, the blots were washed twice in 2  SSC for 15 minutes
at room temperature, once in 2  SSC, 2% SDS for 45Bedford, MA, USA). The nonspecific sites of the mem-
branes were blocked by incubation at room temperature minutes at 65C, and once in 0.1  SSC, 0.1% SDS for
15 minutes at 65C. The blots were then exposed to filmfor 1 hour in 7.5% nonfat dry milk powder in PBS con-
taining 0.1% Tween 20 (PBST). The membranes were at –70C with use of an intensifying screen. Probe for
murine bclx has already been described [16]. The murineincubated overnight at 4C with primary antibody in
PBST containing 5% nonfat dry milk. The membranes probes were prepared by polymerase chain reaction
(PCR) of reverse transcribed total RNA isolated fromwere washed with PBST, and incubated 1 hour at room
temperature with horseradish peroxidase-conjugated MCT cells.
secondary antibody (Amersham, Arlington Heights, IL,
Data presentationUSA) in PBST containing 5% nonfat dry milk. After
washed with PBST, membranes were incubated for 30 Representative data from three to four independent
experiments are presented. For the comparison of groupminutes in PBST containing 400 mm NaCl, followed by
detection with enhanced chemiluminescence (ECL kit, means, analysis of variance (ANOVA) and Student-
Newman-Keuls tests were used as appropriate. A valueAmersham). Films were scanned on a densitometer and
quantified using ImageQuantNT Software (Molecular Dy- P  0.05 was considered statistically significant.
namics, Sunnyvale, CA, USA). The membranes were
stained with Ponceau S to confirm equal loading and
RESULTS
transfer of samples.
Simvastatin induces MCT cell apoptosis
Immunofluorescent staining To evaluate whether HMG-CoA reductase inhibitor
induces apoptosis on MCT cells, exponentially growingMCT cells were grown in four chambers tissue culture-
treated glass slides (Falcon Labware, Lincoln Park, NJ, subconfluent MCT cells were exposed to increasing con-
centrations of the HMG-CoA reductase inhibitor sim-USA). To study cytochrome C localization, cells from
different experimental conditions were washed and fixed in vastatin in the presence of 10% of FBS as a survival factor.
Simvastatin treatment was associated to cell rounding andmethanol/acetone at –20C for 30 minutes. Cells were in-
cubated with 10% goat serum in PBS for 1 hour at room detachment from the plate substrate and surrounding
cells, as assessed by inverted-phase microscopy (Fig. 1).temperature. Rabbit anti-cytochrome C polyclonal anti-
body (sc-7159) was used as primary antibody (10 g/mL) To further confirm that simvastatin induces apoptosis of
MCT cells, the cell DNA content was assessed by flowand a 1/200 dilution of fluorescein isothiocyanate (FITC)-
labeled goat anti-rabbit immunoglobulin G (IgG) was used cytometry. Simvastatin treatment was associated with
the appearance of a cell population with a reduced DNAas secondary antibody (Sigma Chemical Co.). Controls
were stained with nonimmune serum or with the second- content (hypodiploid), usually referred as sub G1 or A0,
characteristic of apoptosis (Fig. 2 A to C). The reductionary antibody alone.
To study annexin-V/propidium iodide staining, cells in cellular DNA content was paralleled by the appear-
ance of DNA fragmentation into multiples of 180 to 200from different experimental conditions were washed and
labeled following Annexin V-Biotin Apoptosis Detec- kb, constituting a typical laddering pattern charactistic
of apoptosis (Fig. 2D). Finally, simvastatin treatmenttion kit following the manufacturer’s instructions (MBL,
Nagoya, Japan). was also associated with increased annexin V binding,
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Fig. 1. Morphologic effects of simvastatin in murine tubular cells (MCT) in culture. Exponentially growing MCT cells were exposed for 24 hours
to simvastatin (1 mol/L), simvastatin  mevalonate (MVA) (100 mol/L) as indicated. Phase contrast microscopic photographs (original
magnification 200). Representative example of at least three independent experiments are shown. Treatment of simvastatin was associated
different degrees of cell rounding and detachment from substrate and surrounding cells. However, overexpression of Bcl-xL prevented, at least
in part, the morphologic changes induced by simvastatin treatment. FBS is fetal bovine serum.
an early indicator of apoptosis, without propidium iodide Simvastatin inhibits Rho prenylation in MCT cells
staining, indicating that this form of death is apoptosis Since FPP and GGPP are used for the transcriptional
(Fig. 3). Some cells were also stained with propidium modification of small G proteins, we next evaluated
iodide indicating a late state of apoptosis (Fig. 3). whether HMG-CoA reductase inhibition was associated
The presence of mevalonate in the culture medium pre- with changes in the level of Rho prenylation. The evalua-
vented the effects of simvastatin in cell morphology, DNA tion of the degree of the presence of Rho in the mem-
content, and fragmentation (Figs. 1 to 3). Statins not only brane or cytoplasm compartments of the cells is an indi-
inhibit cholesterol synthesis, but also inhibit the synthesis rect assessment of its degree of prenylation. Treatment
of MCT with simvastatin was associated with attenuationof important isoprenoid intermediates such as FPP and
of the presence of Rho in the membrane and its appear-GGPP. Both FPP and GGPP reversed apoptosis induced
ance in the cytoplasmic fraction in a dose-dependentby simvastatin in a dose-dependent manner (Fig. 4).
manner. Again, the treatment with mevalonate, GGPP,
Statins treatment changes mRNA and protein levels or FPP was associated, at least in part, with the disap-
of Bcl-xL in MCT cells pearance of Rho from the cytoplasm and its restoration
into membrane (Fig. 8).Next, we analyzed whether statins induce changes in
the expression of different proteins involved in apopto- Statins induce translocation of cytochrome C
sis. For this purpose, growing MCT cells were incubated in MCT cells
to increasing concentrations of simvastatin and we ob-
To examine whether HMG-CoA reductase inhibitorsserved that simvastin down-regulated Bcl-xL protein ex-
induce translocation of cytochrome C, exponentially
pression in MCT cells in a time- and dose-dependent
growing MCT cells were exposed to increasing concen-
manner (Fig. 5). This effect was correlated with a diminu- trations of simvastatin and evaluated by immunostaining
tion of Bcl-xL mRNA in these cells (Fig. 6). However, and Western blot. Treatment with simvastatin was asso-
the treatment with simvastatin did not modify the expres- ciated with attenuation of the presence of cytochrome
sion of the proapoptotic protein Bax (Fig. 5). These C in the mitochondrial fraction and its appearance in
changes resulted in decreased Bcl-xL/Bax ratio (Fig. 5C), the cytoplasmic fraction in a dose-dependent manner
which reflects a change in the balance between cell life- (Fig. 9). Coincubation of MCT cells with mevalonate,
and death-promoting genes. Coincubation of MCT cells FPP, or GGPP prevented the translocation of cyto-
with either mevalonate or isoprenoid FPP and GGPP chrome C. By confocal analysis, cells growing in FBS
prevented the down-regulation of Bcl-xL induced by had a mitochondrial pattern (Fig. 9A), while cells treated
with simvastatin had a cytosolic one.simvastatin (Figs. 6B and 7).
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Fig. 2. Effect of simvastatin on DNA fragmentation. Exponentially growing murine tubular cells (MCT) were exposed to simvastatin (0.1 to 1
mol/L) and simvastatin  mevalonte (MVA) (100 mol/L) for 24 hours, as indicated. (A ) Representative flow cytometry analysis of cell cycle
in control cells and cells treated with simvastatin 1 mol/L and simvastatin  mevalonate 100 mol/L, as indicated. (B and C) Histograms
representing the mean  SD proportion of cells with hypodiploid DNA content (Ao) or triplicate samples. *P  0.05 vs. fetal bovine serum (FBS);
**P  0.05 vs. MCT-wt. (D ) Dose response of simvastatin on DNA fragmentation. Treatment with simvastatin was associated with the appearance
of a 180 to 200 bp DNA fragmentation pattern, typical of apoptosis. This effect was abolished by mevalonate and overexpression of Bcl-xL.
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Fig. 3. Effect of simvastatin on annexin V binding. Exponentially growing murine tubular cells (MCT) were exposed to simvastatin (1 mol/L)
in the absence or presence of mevalonate (MVA) (100 mol/L) as indicated. Cells were exposed to annexin-V biotin and propidium iodide, and
analyzed by confocal microscopy as described in the Methods section. Annexin V binds to phosphatidylserine on the outer layer of cell membrane
and, as such, it is considered as an early feature of apoptosis. Some cells are also labeled with propidium iodide indicating a late state of apoptosis.
Mevalonate and Bcl-xL overexpression reverse the simvastatin-induced effects. Results are representative of three independent experiments.
Statins activate caspase 9 and 3 in MCT cells of mitochondrial pathway through death receptors. As
shown in the Figure 10, we observed no cleaved BidCaspases are the killer proteases that are activated
protein in the different experimental conditions, there-during apoptosis. These proteases are synthesized as in-
fore indicating that this protein is not implicated in apo-active proforms and are activated during apoptosis by
ptosis induced by statins.proteolytic cleavage. To examine whether HMG-CoA
reductase inhibitors induce activation of caspases, expo- Bcl-xL overexpression protects from
nentially growing MCT cells were exposed to increasing statin-induced apoptosis
concentrations of simvastatin and the existence of active The reduction of Bcl-xL/Bax ratio may contribute to
forms of caspase 9 and 3 in the cell lysates were evaluated the increment of apoptosis induced by statins. Support-
by Western blot. We noted the presence of caspase 9 ing this hypothesis, overexpression of Bcl-xL reduced
and 3 during apoptosis induced by simvastatin (Fig. 10), the amount of apoptosis induced by statins by 80% when
while we did not observe activation of caspase 8 (data compared with control vector-expressing cells, as assessed
not shown). Again, mevalonate abolished the presence by flow cytometry, DNA fragmentation, annexin V bind-
of active caspase 9 and 3 in the cell lysates. In addition, ing, and morphologic analysis (Figs. 1 to 3). In addition,
we explored the effect of statins on the expression of overexpression of Bcl-xL prevents caspase 9 and 3 activa-
tion induced by statins in MCT cells (Fig. 10).Bid, a proapoptotic protein implicated in the activation
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Fig. 4. Mevalonate (MVA), farnesylpyrophosphate (FPP), and geran-
ylgeranylpyrophosphate (GGPP) reverse the effects of simvastatin.
Exponentially growing murine tubular cells (MCT) were exposed to
simvastatin (1 mol/L) in the absence or presence of 5 mol/L FPP or
GGPP for 24 hours, as indicated. Histograms representing the mean 
SD proportion of cells with hypodiploid DNA content (Ao) or triplicate
samples. Values are representative of three independent experiments.
Mevalonate, FPP, and GGPP reversed the effects of simvastatin on the
proportion of cells with reduced DNA content (Ao). *P  0.05 vs.
Fig. 6. Effect of simvastatin on Bcl-xL mRNA expression. Exponen-simvastatin 1 mol/L.
tially growing murine tubular cells (MCT) were exposed to different
concentrations of simvastatin. Treatment with simvastatin down-regu-
lated the Bcl-xL expression in a time- (A) and dose-dependent manner
(B). Mevalonate (MVA), farnesylpyrophosphate (FPP), and geranyl-
geranylpyrophosphate (GGPP) reversed the expression of Bcl-xL at basal
levels. Results are representative of three independent experiments.
Fig. 7. Effect of mevalonate (MVA), farnesylpyrophosphate (FPP),
and geranylgeranylpyrophosphate (GGPP) on Bcl-xL protein expres-
sion. Exponentially growing murine tubular cells (MCT) were exposed
to simvastatin (1 mol/L) in presence or absence of different concentra-
tions of mevalonate, FPP or GGPP. Mevalonate, FPP, and GGPP
reversed, in a dose-dependent manner, the effects of simvastatin on Bcl-
xL protein expression. Results are representative of three independent
experiments.
DISCUSSION
Several studies have shown that HMG-CoA reductase
inhibitors induce changes characteristic of apoptosis in
a variety of cell lines [17, 18]; however, the mechanisms
by which statins induce apoptosis in tubular cells are
unknown. Cell death is modulated by a changing balance
in protective and lethal intracellular proteins. In the cur-
rent study, we analyzed the effect of statin treatment inFig. 5. Effect of simvastatin in Bcl-xL protein expression. Exponen-
tially growing murine tubular cells (MCT) were exposed to different Bcl-xL and Bax expression. Bcl-xL, a member of the
concentrations of simvastatin. Treatment with simvastatin down-regu- Bcl-2 family, has two alternatively spliced forms: Bcl-xL
lated the Bcl-xL expression in a time- (A) and dose-dependent manner
and Bcl-xS. Bcl-xL, like Bcl-2, protects cells from a wide(B). Simvastatin decreased Bcl-xL/Bax ratio (Western blot densitome-
try) (C). Results are representative of four independent experiments. variety of apoptotic stimuli [19]. In contrast, Bax is a
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Fig. 8. Effect of simvastatin on Rho A prenyl-
ation. Exponentially growing murine tubular
cells (MCT) were exposed to different concen-
trations of simvastatin in the absence of meval-
onate (MVA), farnesylpyrophosphate (FPP),
and geranylgeranylpyrophosphate (GGPP) for
24 hours, as indicated. Treatment with simva-
statin was associated with an attenuation of
Rho A prenylation, as assessed by a reduced
amount of Rho A in the membrane fractions
and its appearance in the cytoplasmic frac-
tions. The presence of either mevalonate, FPP,
or GGPP in the cultures abrogated the statin
inhibition of Rho A prenylation. Results are
representative of three independent experi-
ments.
Fig. 9. Effect of simvastatin on cytochrome
C localization. Exponentially growing murine
tubular cells (MCT) were exposed to different
concentrations of simvatatin in the presence
or absence of mevalonate (MVA), farnesyl-
pyrophosphate (FPP), and geranylgeranylpyro-
phosphate (GGPP). (A) Confocal analysis and
Western Blot of cytochrome C localization.
Immunofluoresecence staining was performed
with a specific anti-cytochrome C antibody, as
indicated in the Methods section. Cells grow-
ing in the presence of fetal bovine serum
(FBS) showed a typical pattern of mitochon-
drial localization. Simvastatin-treated cells re-
lease cytochrome C from the mitochondria to
the cytosol. (B ) Western Blot of cytochrome
C. Treatment with simvastatin was associated
with a diminution of cytochrome C in the mi-
tochondria extracts, and its appearance in the
cytoplasmic fractions. The presence of either
mevalonate, FPP, or GGPP in the cultures
abrogated the the presence of cytochrome C
in the cytosol fractions. Results are represen-
tative of three independent experiments.
Bcl-2-like protein that binds to and antagonizes the pro- [6]. In the present study, we have observed that HMG-
CoA reductase inhibition by simvastatin results in a re-tective effect of Bcl-2 and Bcl-xL, rendering cells more
sensitive to death [5]. In this sense, we previously have duction of Bcl-xL mRNA and protein expression in a
time- and dose-dependent manner. However, the treat-demonstrated that treatment with HMG-CoA reductase
inhibitors reduces Bcl-2 expression in vascular smooth ment of MCT cells with this statin did not modify Bax
expression. This results in a decreased Bcl-xL/Bax ratio,muscle cells [20]. However, the expression of Bcl-2 in
tubular cells is minimal and Bcl-xL is apparently more favoring therefore the cell death.
HMG-CoA reductase inhibition causes a reduction inimportant in the regulation of cell death in these cells
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Fig. 10. Effect of simvastatin on caspases ac-
tivation. Exponentially growing murine tubu-
lar cells (MCT) were exposed to different con-
centrations of simvastatin. (A ) The treatment
with simvastatin induces activation of caspase
9. However, no change was observed in Bid
expression. Simvastatin-treatment also acti-
vated caspase 3 in a dose- (B) and time-depen-
dent manner (C). Mevalonate and overex-
pression of Bcl-xL abolished this activation.
Results are representative of four indepen-
dent experiments.
the cellular content of a variety of mevalonate metabo- lated, the cytochrome C is released from mitochondria
and forms an essential part of the vertebrate “apopto-lites [21, 22]. In this sense, we have observed that mevalo-
nate abolished apoptosis induced by statins, indicating some,” which is composed of cytochrome C, Apaf-1, and
procaspase 9 [24]. For this reason, we analyzed the effecta direct effect of HMG-CoA reductase inhibition on
apoptosis of tubular cells. In addition, we analyzed the of simvastatin on cytochrome C release from the mito-
chondria and we observed that simvastatin induced theimportance of isoprenoids related with the mevalonate
pathway in the expression of Bcl-xL, and we have ob- accumulation of cytochrome C in the cytosol. In addition,
mevalonate, FPP, and GGPP reversed the effect inducedserved that FPP and GGPP reversed Bcl-xL expression
at basal levels, indicating that isoprenoids, probably by simvastatin on cytochrome C localization.
Next, we evaluated the effects of HMG-CoA reduc-through prenylation of proteins, can be involved in the
regulation of Bcl-xL expression. In addition, we have tase inhibitors on caspase activation. The caspases are
important mediators of the final steps of apoptosis [25].also noted that treatment with simvastatin decreased
Bcl-xL expression associated with a diminution of Rho At least 14 members of this family have been described.
Their genes encode proteins that are translated as inac-prenylation. This is in line with the observation that Rho
inhibition caused apoptosis in other cell lines [20, 23]. tive proenzymes. The precursors are activated by cleav-
age after specific aspartate residues and assembly intoIncreasing evidence suggest that the function of Bcl-
xL is strongly related to the regulation of protein translo- heterotetramers. Proteolytic targets of activated caspases
include other caspases, poly (ADP-ribose) polymerasecation from the mitochondrial intermembrane space into
the cytosolic compartment. When Bcl-xL is down-regu- (PARP), laminin A, -fodrin, Bcl-2 family members, and
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other proteins [26, 27]. The release of cytochrome C CONCLUSION
to cytosol induces activation of caspase 9, which then The present study shows the potential implication of
processes and activates other caspases, like caspase 3, to Bcl-xL in apoptosis induced by HMG-CoA reductase
orchestrate the biochemical execution of cells. For this inhibitors in tubular cells. These results may be related
reason, we studied the effect of HMG-CoA reductase to the observed beneficial effects of statins on polycystic
inhibitors on caspase 9 and 3 activation, and we observed kidney disease. However, their relevance in vivo needs
that simvastatin induced caspase 9 and 3 activation. to be further addressed.
Again, mevalonate, FPP, and GGPP abolished the pres-
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